Correlation Between Antisense Therapeutics and Bionoid Pharma
Can any of the company-specific risk be diversified away by investing in both Antisense Therapeutics and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antisense Therapeutics and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antisense Therapeutics Limited and Bionoid Pharma, you can compare the effects of market volatilities on Antisense Therapeutics and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antisense Therapeutics with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antisense Therapeutics and Bionoid Pharma.
Diversification Opportunities for Antisense Therapeutics and Bionoid Pharma
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Antisense and Bionoid is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Antisense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antisense Therapeutics Limited are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Antisense Therapeutics i.e., Antisense Therapeutics and Bionoid Pharma go up and down completely randomly.
Pair Corralation between Antisense Therapeutics and Bionoid Pharma
Assuming the 90 days horizon Antisense Therapeutics Limited is expected to under-perform the Bionoid Pharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, Antisense Therapeutics Limited is 5.16 times less risky than Bionoid Pharma. The pink sheet trades about -0.31 of its potential returns per unit of risk. The Bionoid Pharma is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 25.00 in Bionoid Pharma on August 25, 2024 and sell it today you would lose (5.00) from holding Bionoid Pharma or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Antisense Therapeutics Limited vs. Bionoid Pharma
Performance |
| Timeline |
| Antisense Therapeutics |
| Bionoid Pharma |
Antisense Therapeutics and Bionoid Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Antisense Therapeutics and Bionoid Pharma
The main advantage of trading using opposite Antisense Therapeutics and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antisense Therapeutics position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.| Antisense Therapeutics vs. Green Cures Botanical | Antisense Therapeutics vs. Galexxy Holdings | Antisense Therapeutics vs. Indoor Harvest Corp | Antisense Therapeutics vs. Speakeasy Cannabis Club |
| Bionoid Pharma vs. Green Cures Botanical | Bionoid Pharma vs. Galexxy Holdings | Bionoid Pharma vs. Indoor Harvest Corp | Bionoid Pharma vs. Speakeasy Cannabis Club |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |